Ruane, Cunniff & Goldfarb’s West Pharmaceutical WST Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,944	Closed	-$2.83M	–	69
2018 Q3	$2.83M	Sell	22,944 -256	-1%	-$28.7K	0.03%	41
2018 Q2	$2.3M	Sell	23,200 -1,334	-5%	-$123K	0.02%	43
2018 Q1	$2.12M	Sell	24,534 -1,179	-5%	-$110K	0.02%	43
2017 Q4	$2.54M	Sell	25,713 -15,670	-38%	-$1.54M	0.02%	49
2017 Q3	$3.98M	Sell	41,383 -1,411	-3%	-$128K	0.03%	53
2017 Q2	$4.04M	Sell	42,794 -16,948	-28%	-$1.56M	0.04%	52
2017 Q1	$4.88M	Sell	59,742 -314,039	-84%	-$26.3M	0.05%	53
2016 Q4	$31.7M	Sell	373,781 -50,686	-12%	-$3.99M	0.3%	42
2016 Q3	$31.6M	Sell	424,467 -18,552	-4%	-$1.47M	0.3%	42
2016 Q2	$33.6M	Sell	443,019 -90,631	-17%	-$6.6M	0.32%	41
2016 Q1	$37M	Sell	533,650 -458,278	-46%	-$27.6M	0.29%	41
2015 Q4	$59.7M	Sell	991,928 -17,651	-2%	-$1.06M	0.34%	37
2015 Q3	$54.6M	Sell	1,009,579 -6,372	-0.6%	-$371K	0.28%	38
2015 Q2	$59M	Sell	1,015,951 -6,202	-0.6%	-$346K	0.28%	39
2015 Q1	$61.5M	Sell	1,022,153 -2,263	-0.2%	-$121K	0.29%	38
2014 Q4	$54.5M	Sell	1,024,416 -4,049	-0.4%	-$203K	0.28%	38
2014 Q3	$46M	Sell	1,028,465 -28,236	-3%	-$1.2M	0.24%	41
2014 Q2	$44.6M	Sell	1,056,701 -4,702	-0.4%	-$201K	0.24%	41
2014 Q1	$46.8M	Sell	1,061,403 -6,726	-0.6%	-$317K	0.25%	39
2013 Q4	$52.4M	Sell	1,068,129 -12,684	-1%	-$594K	0.29%	37
2013 Q3	$44.5M	Sell	1,080,813 -41,449	-4%	-$1.58M	0.26%	39
2013 Q2	$39.4M	Buy	+1,122,262	New	+$36.9M	0.25%	37

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's WST Position: Q4 2018 in Review

Ruane, Cunniff & Goldfarb sold out of West Pharmaceutical (WST) in Q4 2018, closing a stake of 22,944 shares — an estimated $2.83M sold.

Ruane, Cunniff & Goldfarb first reported a position in WST in Q2 2013 and held it in 22 quarters. The position peaked at $61.5M in Q1 2015. 355 funds tracked by Wall St. Rank hold WST as of Q4 2018.

Ruane, Cunniff & Goldfarb reported no remaining West Pharmaceutical position as of Q4 2018 after selling out during the quarter.
Ruane, Cunniff & Goldfarb sold 22,944 West Pharmaceutical shares in Q4 2018, an estimated $2.83M.
Ruane, Cunniff & Goldfarb first reported a position in West Pharmaceutical in Q2 2013 and held it in 22 quarters.
Ruane, Cunniff & Goldfarb's West Pharmaceutical position peaked at $61.5M in Q1 2015.
355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2018.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q4 2018, filed 14 Feb 2019.